BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fazalul Rahiman SS, Morgan M, Gray P, Shaw PN, Cabot PJ. Dynorphin 1-17 and Its N-Terminal Biotransformation Fragments Modulate Lipopolysaccharide-Stimulated Nuclear Factor-kappa B Nuclear Translocation, Interleukin-1beta and Tumor Necrosis Factor-alpha in Differentiated THP-1 Cells. PLoS One 2016;11:e0153005. [PMID: 27055013 DOI: 10.1371/journal.pone.0153005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Bodnar RJ. Endogenous Opiates and Behavior: 2016. Peptides 2018;101:167-212. [DOI: 10.1016/j.peptides.2018.01.011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 9.3] [Reference Citation Analysis]
2 Nissen MD, Lau ETL, Cabot PJ, Steadman KJ. Baltic amber teething necklaces: could succinic acid leaching from beads provide anti-inflammatory effects? BMC Complement Altern Med 2019;19:162. [PMID: 31277614 DOI: 10.1186/s12906-019-2574-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Zhang P, Yang M, Chen C, Liu L, Wei X, Zeng S. Toll-Like Receptor 4 (TLR4)/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility. Front Immunol 2020;11:1455. [PMID: 32733481 DOI: 10.3389/fimmu.2020.01455] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
4 Morgan M, Heffernan A, Benhabib F, Wagner S, Hewavitharana A, Shaw P, Cabot P. The efficacy of Dynorphin fragments at the κ, μ and δ opioid receptor in transfected HEK cells and in an animal model of unilateral peripheral inflammation. Peptides 2017;89:9-16. [DOI: 10.1016/j.peptides.2016.12.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
5 Cissom C, J Paris J, Shariat-Madar Z. Dynorphins in Development and Disease: Implications for Cardiovascular Disease. Curr Mol Med 2020;20:259-74. [PMID: 31746302 DOI: 10.2174/1566524019666191028122559] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 D'Ângelo MQ, Queiroz-Junior CM, Maltos KLM, Ferreira AJ, Pacheco CMDF, Soares RV. The blockade of kappa opioid receptors exacerbates alveolar bone resorption in rats. Arch Oral Biol 2020;120:104923. [PMID: 33091661 DOI: 10.1016/j.archoralbio.2020.104923] [Reference Citation Analysis]
7 Rahiman SSF, Morgan M, Gray P, Shaw PN, Cabot PJ. Inhibitory effects of dynorphin 3-14 on the lipopolysaccharide-induced toll-like receptor 4 signalling pathway. Peptides 2017;90:48-54. [PMID: 28219695 DOI: 10.1016/j.peptides.2017.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
8 Gabr MM, Saeed I, Miles JA, Ross BP, Shaw PN, Hollmann MW, Parat MO. Interaction of Opioids with TLR4-Mechanisms and Ramifications. Cancers (Basel) 2021;13:5274. [PMID: 34771442 DOI: 10.3390/cancers13215274] [Reference Citation Analysis]